Mechanism of nitrofen teratogenesis

Environmental Health Perspectives
J M Manson

Abstract

Nitrofen (2,4-dichloro-4'-nitrodiphenyl ether) is an herbicide with potent teratogenic activity in rats. When administered at doses as low as 0.15 mg/kg/day during organogenesis, abnormal development of the heart, kidneys, diaphragm, and lung occurs. The specific pattern of visceral malformations produced in the absence of overt maternal toxicity or embryolethality/cytotoxicity suggest that the compound perturbs processes unique or highly selective for embryonic differentiation. Despite findings of metabolic activation to mutagenic intermediates and carcinogenic activity in adult rodents, several lines of evidence indicate that teratogenicity is not based on mutagenic insult to the embryo. Rather, evidence is accumulating that nitrofen exerts a teratogenic effect via alterations in thyroid hormone status. The premature and pharmacologic exposure of the embryo to a nitrofen-derived thyromimetic challenge is believed to be the cause of abnormal morphogenesis of the heart, lungs, kidneys, and diaphragm. The parent compound itself could directly bind to embryonic nuclear receptors for T3, leading to altered differentiation of target organs. Alternatively, increased availability and placental transport of free thyroid hormones in th...Continue Reading

References

Apr 1, 1996·Pediatric Surgery International·B QiJ A Tovar
Dec 10, 2015·Pediatric Surgery International·Hiromizu TakahashiPrem Puri
Dec 17, 2004·Birth Defects Research. Part A, Clinical and Molecular Teratology·Marieke van DoorenClaudine Torfs
Dec 1, 1992·Teratology·C P TorfsL H Honoré
May 1, 2007·Birth Defects Research. Part A, Clinical and Molecular Teratology·Niels BeurskensDick Tibboel
Apr 17, 2007·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·David E Kling, Jay J Schnitzer
Dec 8, 2004·Toxicology in Vitro : an International Journal Published in Association with BIBRA·David E KlingJay J Schnitzer
Oct 1, 1995·Journal of Pediatric Surgery·Q BaoquanJ A Tovar
Sep 27, 2007·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Jeremy T AidlenDavid E Kling
Jun 17, 2008·Birth Defects Research. Part A, Clinical and Molecular Teratology·MaryAnn Vitoria VolpeMala Romeshchandra Chinoy
Nov 1, 2008·Bulletin of Environmental Contamination and Toxicology·Zongming RenRongshu Fu
Aug 28, 2009·Birth Defects Research. Part A, Clinical and Molecular Teratology·Robin D ClugstonJ J Greer
Jun 16, 2010·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·David E KlingDavid S Newburg
Feb 24, 2006·Biology of the Neonate·Salome Gonzalez-ReyesJ A Tovar
Aug 21, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·B Rhiannon NobleJ J Greer
Jul 3, 2020·BMJ : British Medical Journal·Rodrigo Ruano

Citations

Dec 1, 1985·Endocrinology·A Perez-CastilloT Pans
Sep 1, 1986·Toxicology·B M Francis
Oct 1, 1974·British Journal of Orthodontics·A K Tipnis
Mar 1, 1972·Journal of Agricultural and Food Chemistry·E A WoolsonP D Ensor
Dec 1, 1983·Toxicology·S S HurtA W Hayes
Mar 1, 1983·Journal of Agricultural and Food Chemistry·W M Draper, J E Casida

Related Concepts

Embryo
Exertion
Entire Diaphragm
Lung
Entire Embryo
1,3-dichlorophenyl-p-nitrophenyl ether
Placenta
Kidney
Organ
Cell Differentiation Process

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.